IDUNN / MC-MSC.1

Hematological neoplasms
Other indications (e.g. myeloproliferative diseases)
Follow-Up Treatment
MSCs (MC0518) vs. BAT in subjects with steroid-refractory aGvHD after allogeneic HSCT
MSCs (MC0518) vs. BAT in subjects with steroid-refractory aGvHD after allogeneic HSCT